期刊文献+

Smoking increases the risk of extraintestinal manifestations in Crohn's disease 被引量:2

Smoking increases the risk of extraintestinal manifestations in Crohn's disease
下载PDF
导出
摘要 AIM:To demonstrate a high prevalence of extraintestinal manifestations(EIMs)in a prospective populationbased cohort of inflammatory bowel disease(IBD)patients at first diagnosis as well as during the early course of the disease.METHODS:EIMs are common in patients with IBD.Data on the frequency of EIMs have mostly been assessed in patients from tertiary centers;however,data about the prevalence of EIMs at first diagnosis as well as factors influencing their incidence during the early course of disease from prospective population-based cohorts are scarce.We present data of patients of our population-based"Oberpfalz cohort"(Bavaria,Germany)from first diagnosis(up to 3 mo after first diagnosis)as well as during the early course of the disease.Possible risk factors were assessed by calculating the relative risk(RR)as well as using logistic regression analysis.RESULTS:In total,data of 257 newly diagnosed patients with IBD were evaluated[161 Crohn’s disease(CD),96 ulcerative colitis(UC)].Median duration of follow-up was 50 mo after first diagnosis.In 63.4%of all patients(n=163),an EIM was diagnosed at any point during the observation period.At first diagnosis,patients with CD had a significantly increased risk of an EIM[n=69(42.9%)]compared with UC patients[n=21(21.9%);P<0.001;RR=1.96;95%CI:1.30-2.98].Active smoking increased the risk of CD patients developing an EIM during the early course of the disease,but notably not of UC patients(P=0.046;RR=1.96;95%CI:1.01-3.79).In addition,using logistic regression analysis,the need for IBD-related surgery and a young age at first diagnosis were identified as risk factors for the development of an EIM in CD patients.No association with EIMs was found for the factors sex,localization of the disease and positive family history of IBD.In contrast,no key factors which increased the risk of development of an EIM could be identified in UC patients.CONCLUSION:We found a high prevalence of EIM in this cohort at first diagnosis and during the early course of the disease.In patients with CD,smoking,need for surgery and younger age at first diagnosis were risk factors for the development of an EIM. AIM:To demonstrate a high prevalence of extraintestinal manifestations(EIMs)in a prospective populationbased cohort of inflammatory bowel disease(IBD)patients at first diagnosis as well as during the early course of the disease.METHODS:EIMs are common in patients with IBD.Data on the frequency of EIMs have mostly been assessed in patients from tertiary centers;however,data about the prevalence of EIMs at first diagnosis as well as factors influencing their incidence during the early course of disease from prospective population-based cohorts are scarce.We present data of patients of our population-based'Oberpfalz cohort'(Bavaria,Germany)from first diagnosis(up to 3 mo after first diagnosis)as well as during the early course of the disease.Possible risk factors were assessed by calculating the relative risk(RR)as well as using logistic regression analysis.RESULTS:In total,data of 257 newly diagnosed patients with IBD were evaluated[161 Crohn’s disease(CD),96 ulcerative colitis(UC)].Median duration of follow-up was 50 mo after first diagnosis.In 63.4%of all patients(n=163),an EIM was diagnosed at any point during the observation period.At first diagnosis,patients with CD had a significantly increased risk of an EIM[n=69(42.9%)]compared with UC patients[n=21(21.9%);P<0.001;RR=1.96;95%CI:1.30-2.98].Active smoking increased the risk of CD patients developing an EIM during the early course of the disease,but notably not of UC patients(P=0.046;RR=1.96;95%CI:1.01-3.79).In addition,using logistic regression analysis,the need for IBD-related surgery and a young age at first diagnosis were identified as risk factors for the development of an EIM in CD patients.No association with EIMs was found for the factors sex,localization of the disease and positive family history of IBD.In contrast,no key factors which increased the risk of development of an EIM could be identified in UC patients.CONCLUSION:We found a high prevalence of EIM in this cohort at first diagnosis and during the early course of the disease.In patients with CD,smoking,need for surgery and younger age at first diagnosis were risk factors for the development of an EIM.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第34期12269-12276,共8页 世界胃肠病学杂志(英文版)
关键词 Extraintestinal MANIFESTATIONS Crohn’s DISEASE Ulc Extraintestinal manifestations Crohn's disease Ulcerative colitis Smoking Surgery Age at onset
  • 相关文献

参考文献13

  • 1Fernando Tavarela Veloso.Extraintestinal manifestations of inflammatory bowel disease:Do they influence treatment and outcome?[J].World Journal of Gastroenterology,2011,17(22):2702-2707. 被引量:13
  • 2CAOQian,SIJian-min,GAOMin,ZHOUGang,HUWei-ling,LIJin-hong.Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China[J].Chinese Medical Journal,2005(9):747-752. 被引量:8
  • 3Laszlo Lakatos,Tunde Pandur,Gyula David,Zsuzsanna Balogh,Pal Kuronya,Arpad Tollas,Peter Laszlo Lakatos.Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype:Results of a 25-year follow-up study[J].World Journal of Gastroenterology,2003,9(10):2300-2307. 被引量:25
  • 4Fengming Yi,Min Chen,Meifang Huang,Jin Li,Junzhang Zhao,Lixia Li,Bing Xia.The trend in newly diagnosed Crohn’s disease and extraintestinal manifestations of Crohn’s disease in central China: a retrospective study of a single center[J].European Journal of Gastroenterology & Hepatology.2012(12)
  • 5Gaurav Arora,Gurkirpal Singh,Shweta Vadhavkar,Shamita B. Shah,Ajitha Mannalithara,Alka Mithal,George Triadafilopoulos.Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based Study[J].Digestive Diseases and Sciences.2010(6)
  • 6Claudia Ott,Florian Obermeier,Sabine Thieler,Daniela Kemptner,Alexandra Bauer,Jürgen Sch?lmerich,Gerhard Rogler,Antje Timmer.The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study[J].European Journal of Gastroenterology & Hepatology.2008(9)
  • 7Jolanda M. White,Siobhán O’Connor,Harland S. Winter,Melvin B. Heyman,Barbara S. Kirschner,George D. Ferry,Stanley A. Cohen,Robert N. Baldassano,Terry Smith,Traci Clemons,Benjamin D. Gold.Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry[J].Clinical Gastroenterology and Hepatology.2008(12)
  • 8Folashade A Jose,Melvin B Heyman.Extraintestinal Manifestations of Inflammatory Bowel Disease[J].Journal of Pediatric Gastroenterology and Nutrition.2008(2)
  • 9Manuel Barreiro-de Acosta,J. Enrique Domínguez-Mu?oz,M. Concepcion Nú?ez-Pardo de Vera,Antonio Lozano-León,Aurelio Lorenzo,Salvador Pe?a.Relationship between clinical features of Crohn?s disease and the risk of developing extraintestinal manifestations[J].European Journal of Gastroenterology & Hepatology.2007(1)
  • 10ElenaRicart,RemoPanaccione,Edward V.Loftus,William J.Tremaine,W. ScottHarmsen,Alan R.Zinsmeister,William J.Sandborn.Autoimmune disorders and extraintestinal manifestations in first‐degree familial and sporadic inflammatory bowel disease. A case–control study[J].Inflamm Bowel Dis.2006(3)

二级参考文献52

  • 1Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55:401-412.
  • 2Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23:29-34.
  • 3Snook JA, de Silva HJ, Jewell DP. The association of autoim- mune disorders with inflammatory bowel disease. Q J Med 1989; 72:835-840.
  • 4Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Co- operative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77:914-920.
  • 5Bernstein CN, Blanchard JF, Rawsthome P, Yu N. The preva- lence of extraintestinal diseases in inflammatory bowel dis- ease: a population-based study. Am J Gastroenterol 2001; 96: 1116-1122.
  • 6Veloso Fr, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the vienna classifica- tion and clinical activity. Inflamm Bowel Dis 2001; 7:306-313.
  • 7Veloso FT. Extraintestinal manifestations - important target of treatment or just an expression of disease activity? In: Herfarth H, Feagan BG, Folsch UR, Scholmerich J, Vatn MH, Zeitz M, editors. Targets of treatment in chronic inflamma- tory bowel diseases. Dordrecht: Kluwer Academic Publish- ers, 2003:163-168.
  • 8Meuwissen SGM, Crusius JBA, Pena AS, Dekker-Saeys AJ, Dijkmans BAC. Spondyloarthropathy and idiopathic inflam- matory bowel diseases. Inflamm Bowel Dis 1997; 3:25-37.
  • 9De Vos M. Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 Suppl 4:3642.
  • 10Williams H, Orchard T. Management of the extraintestinal manifestations of IBD. Inflamm Bowel Dis Monit 2009; 10:11-17.

共引文献47

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部